ConductScience.org, home

Paper41880378

Inhibition of transient receptor potential vanilloid 1 (TRPV1) by a novel selective antagonist for anti-nociceptive effect on inflammatory pain without hyperthermia.

Guan J and 3 others. PLoS One, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Inhibition of transient receptor potential vanilloid 1 (TRPV1) by a novel selective antagonist for anti-nociceptive effect on inflammatory pain without hyperthermia. Papers, record 41880378. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41880378

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Inhibition of transient receptor potential vanilloid 1 (TRPV1) by a novel selective antagonist for anti-nociceptive effect on inflammatory pain without hyperthermia.
PubMed
Journal
PLoS One
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Guan JJialianghttps://orcid.org/0000-0003-2608-2449
2Zhao CChenru
3Zhou QQiqi
4Zhu CChaohttps://orcid.org/0000-0002-7596-4723

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
TRPV Cation ChannelsMajor topic
AnalgesicsMajor topic
InflammationMajor topic
PainMajor topic
UreaMajor topic
Animals
Mice
Humans
Male
HEK293 Cells
Hyperthermia
Molecular Docking Simulation

Source PubMed

Download CSV of topics

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131926897Hyperthermia induced by transient receptor potential vanilloid-1 (TRPV1) antagonists in human clinical trials: Insights from mathematical modeling and meta-analysis.Pharmacol Ther2020https://conductscience.org/library/papers/31926897PubMed
223278358The contribution of the endogenous TRPV1 ligands 9-HODE and 13-HODE to nociceptive processing and their role in peripheral inflammatory pain mechanisms.Br J Pharmacol2013https://conductscience.org/library/papers/23278358PubMed
326420335A pain-inducing centipede toxin targets the heat activation machinery of nociceptor TRPV1.Nat Commun2015https://conductscience.org/library/papers/26420335PubMed
428364279TRPV1 and TRPA1 in cutaneous neurogenic and chronic inflammation: pro-inflammatory response induced by their activation and their sensitization.Protein Cell2017https://conductscience.org/library/papers/28364279PubMed
533501656A plant-derived TRPV3 inhibitor suppresses pain and itch.Br J Pharmacol2021https://conductscience.org/library/papers/33501656PubMed
624394343Experiences with an adaptive design for a dose-finding study in patients with osteoarthritis.Contemp Clin Trials2014https://conductscience.org/library/papers/24394343PubMed
717652633Repeated administration of vanilloid receptor TRPV1 antagonists attenuates hyperthermia elicited by TRPV1 blockade.J Pharmacol Exp Ther2007https://conductscience.org/library/papers/17652633PubMed
830699097
Islet-cell autoantigen 69 mediates the antihyperalgesic effects of electroacupuncture on inflammatory pain by regulating spinal glutamate receptor subunit 2 phosphorylation through protein interacting with C-kinase 1 in mice.
Pain2019https://conductscience.org/library/papers/30699097PubMed
917325193Thermosensitive TRPV channel subunits coassemble into heteromeric channels with intermediate conductance and gating properties.J Gen Physiol2007https://conductscience.org/library/papers/17325193PubMed
1011418861Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition.Nature2001https://conductscience.org/library/papers/11418861PubMed
1138776567Discovery of first-in-class highly selective TRPV1 antagonists with dual analgesic and hypoglycemic effects.Bioorg Med Chem2024https://conductscience.org/library/papers/38776567PubMed
1224861977TRPV1: A Potential Drug Target for Treating Various Diseases.Cells2014https://conductscience.org/library/papers/24861977PubMed
1327537761
A Systematic Review and Meta-Analysis of the Global Burden of Chronic Pain Without Clear Etiology in Low- and Middle-Income Countries: Trends in Heterogeneous Data and a Proposal for New Assessment Methods.
Anesth Analg2016https://conductscience.org/library/papers/27537761PubMed
1436008373
Discovery of Potent and Selective Transient Receptor Potential Vanilloid 1 (TRPV1) Agonists with Analgesic Effects In Vivo Based on the Functional Conversion Induced by Altering the Orientation of the Indazole Core.
J Med Chem2022https://conductscience.org/library/papers/36008373PubMed
1534062143Chronic pain: an update on burden, best practices, and new advances.Lancet2021https://conductscience.org/library/papers/34062143PubMed
1633359917Active components of Bupleurum chinense and Angelica biserrata showed analgesic effects in formalin induced pain by acting on Nav1.7.J Ethnopharmacol2021https://conductscience.org/library/papers/33359917PubMed
1721575625Characterization of 2-(2,6-dichloro-benzyl)-thiazolo[5,4-d]pyrimidin-7-yl]-(4-trifluoromethyl-phenyl)-amine (JNJ-39729209) as a novel TRPV1 antagonist.Eur J Pharmacol2011https://conductscience.org/library/papers/21575625PubMed
1833165872TRPV1-Targeted Drugs in Development for Human Pain Conditions.Drugs2021https://conductscience.org/library/papers/33165872PubMed
1925590988The role of TRPV1 channels in carrageenan-induced mechanical hyperalgesia in mice.Neuroreport2015https://conductscience.org/library/papers/25590988PubMed
2018337008Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans.Pain2008https://conductscience.org/library/papers/18337008PubMed

See all 39 referencesDownload CSV of references

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ERG2078PubTator's text mininghttps://conductscience.org/library/genes/2078NCBI Gene
KCNH23757PubTator's text mininghttps://conductscience.org/library/genes/3757NCBI Gene
SCN5A6331PubTator's text mininghttps://conductscience.org/library/genes/6331NCBI Gene
TRPV17442PubTator's text mininghttps://conductscience.org/library/genes/7442NCBI Gene
TRPV251393PubTator's text mininghttps://conductscience.org/library/genes/51393NCBI Gene
TRPV3162514PubTator's text mininghttps://conductscience.org/library/genes/162514NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41880378

GET https://conductscience.org/api/papers/v1/41880378/references?page=2